Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

The Molecular Diagnostics - Infectious Disease sector offers growth opportunities with biotech advancements, particularly in genomics. Key trends include nucleic acid testing and immunoassay ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

Analysts launch bullish coverage on BillionToOne as its IPO surge, prenatal growth, and molecular diagnostics platform drive ...

A stronger domestic industry will not just boost the local industry and reduce the import bill but also ensure that ...

Shard Diagnostic has become the latest company to join the University of Nottingham's investment portfolio, supported through ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...

Diagnostics, Inc. held a special meeting of shareholders where a proposal to amend the company’s Articles of Incorporation was approved. This amendment allows for a reverse stock split of the ...

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its ...